Katja Rohwedder

机构：Brigham and Women's Hospital, Harvard University, MSB Medical School Berlin, Bayer (Germany)

发表论文 133 篇 · 总被引 2097 次 · h-index 16

代表论文

• A FIDELITY Analysis on Finerenone With SGLT-2i and GLP-1RA in CKD (2025 · Kidney International Reports · 被引 6)
• Efficacy and Safety of the Kidney Function–Based Finerenone Dosing Strategy Used in FINEARTS-HF (2026 · JACC Heart Failure · 被引 3)
• Finerenone, Liver Biomarkers, and Heart Failure With Mildly Reduced/Preserved Ejection Fraction: An Analysis of FINEARTS-HF (2026 · Circulation Heart Failure · 被引 3)
• Finerenone and Cardiovascular Outcomes According to Baseline Kidney Function in Patients With Heart Failure (2025 · JACC Heart Failure · 被引 3)
• Effects of Finerenone on Heart Failure Outcomes According to Baseline Heart Failure Risk in Chronic Kidney Disease and Type 2 Diabetes (2026 · JACC Heart Failure · 被引 1)
• Efficacy of finerenone in patients with heart failure and mildly reduced or preserved ejection fraction: a prespecified analysis of heart rate and heart rhythm in the FINEARTS-HF trial (2026 · European Journal of Heart Failure · 被引 1)